Actinogen boosts trial with Cambridge Cognition's digital suite - PharmaTimes Partnership aims to advance Alzheimer's research with innovative tools

#digitalneuroscience #brainhealth #Actinogen #ActinogenMedical #neuropsychiatricdiseases #CambridgeCognition #emestedastat #Xanamem #CANTABAttention #Alzheimersresearch #AlzheimersDisease #XanaMIAclinicaltrail #dementia #plasmabiomarker #biomarker #pTau181
pharmatimes.com/news/actinog...